Steven Cohen Royalty Pharma PLC Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 526,633 shares of RPRX stock, worth $13.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

526,633

Holding current value

$13.5 Million

% of portfolio

0.04%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $13.5 Million - $15.4 Million	526,633 New	526,633 $14.9 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $17.8 Million - $20.3 Million	-647,600 Reduced 55.41%	521,200 $15.8 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $11.5 Million - $12.9 Million	440,600 Added 60.51%	1,168,800 $32.8 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $5.2 Million - $6.21 Million	198,000 Added 37.34%	728,200 $19.8 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $2.62 Million - $3.24 Million	-88,600 Reduced 14.32%	530,200 $16.3 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $20.3 Million - $24.4 Million	618,800 New	618,800 $22.3 Million
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $71 Million - $83.7 Million	-1,892,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $58.3 Million - $66.1 Million	1,556,800 Added 463.2%	1,892,900 $73.7 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $9.74 Million - $11.8 Million	277,000 Added 468.7%	336,100 $13.4 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $2.14 Million - $2.5 Million	59,100 New	59,100 $2.14 Million

Others Institutions Holding RPRX

# of Institutions

412

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account